Development of a Monoclonal Antibody Against NIpah and Hendra Viruses

生物制药产品开发服务项目提供服务，以促进来自生物技术过程的材料的临床前开发，如单克隆抗体和单克隆抗体的衍生物；重组蛋白;肽;核酸载体（siRNA、质粒）；以及活的，被修改的活的和/或弱化的实体。服务内容包括：产品开发策划与评估；分析开发和产品释放测试；工艺开发和制定；GMP制造;监管CMC文件支持。

The Biopharmaceutical Product Development Services program provides services to facilitate preclinical development of materials that are derived from biotechnology processes, such as monoclonal antibodies and derivatives of monoclonal antibodies; recombinant proteins; peptides; nucleic acid based vectors (siRNA, plasmids); and live, modified-live and/or attenuated entities. Services include: product development planning and evaluation; assay development and product release testing; process development and formulation; GMP manufacturing; and regulatory CMC documentation support.